Genetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs

Immunology and Allergy Clinics of North America

Volumn 33, Issue 2, 2013, Pages 177-194

  Kim, Seung Hyun ^a   Sanak, Marek ^a,b   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Genetic association; Hypersensitivity; Nonsteroidal anti inflammatory drugs

Indexed keywords

ABC TRANSPORTER A1; ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR; ANGIOTENSINOGEN; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ARYLAMINE ACETYLTRANSFERASE; COMPLEMENT COMPONENT C6; CYCLOOXYGENASE 2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; DIPEPTIDYL CARBOXYPEPTIDASE; HISTAMINE METHYLTRANSFERASE; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E RECEPTOR; THROMBOXANE A2 RECEPTOR; THROMBOXANE SYNTHASE; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR; UNINDEXED DRUG;

AMINO ACID SUBSTITUTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN INDUCED URTICARIA; CHRONIC INFLAMMATION; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG INACTIVATION; DRUG METABOLISM; DRUG RESPONSE; DRUG TARGETING; EFFECTOR CELL; EPIGENETICS; EPITHELIUM CELL; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; PATHOGENESIS; PHARMACOGENETICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG HYPERSENSITIVITY; HUMANS;

EID: 84877060989     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.10.003     Document Type: Review

References (115)

1. Szczeklik A., Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003, 111:913-921. [quiz: 922].
2. Stevenson D.D., Sanchez-Borges M., Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177-180.
3. Grattan C.E. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003, 28:123-127.
4. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011, 66:818-829.
5. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990, 3:588-593.
6. Celik G., Bavbek S., Misirligil Z., et al. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients. Clin Exp Allergy 2001, 31:1615-1622.
7. Kowalski M.L., Pawliczak R., Wozniak J., et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000, 161:391-398.
8. In K.H., Asano K., Beier D., et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997, 99:1130-1137.
9. Sanak M., Simon H.U., Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997, 350:1599-1600.
10. Peters-Golden M., Henderson W.R. Leukotrienes. N Engl J Med 2007, 357:1841-1854.
11. Sanak M., Pierzchalska M., Bazan-Socha S., et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000, 23:290-296.
12. Cowburn A.S., Sladek K., Soja J., et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998, 101:834-846.
13. Cai Y., Bjermer L., Halstensen T.S. Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma. Am J Respir Cell Mol Biol 2003, 29:683-693.
14. Adamjee J., Suh Y.J., Park H.S., et al. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol 2006, 209:392-399.
15. Kim S.H., Bae J.S., Suh C.H., et al. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy 2005, 60:760-765.
16. Drazen J.M. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma. Pharmacotherapy 1997, 17:22S-30S.
17. Kim S.H., Oh J.M., Kim Y.S., et al. Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 2006, 36:433-439.
18. Sousa A.R., Parikh A., Scadding G., et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1493-1499.
19. Kim S.H., Ye Y.M., Hur G.Y., et al. CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 2007, 8:1143-1150.
20. Park J.S., Chang H.S., Park C.S., et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 2005, 15:483-492.
21. Farooque S.P., Lee T.H. Aspirin-sensitive respiratory disease. Annu Rev Physiol 2009, 71:465-487.
22. Ciana P., Fumagalli M., Trincavelli M.L., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 2006, 25:4615-4627.
23. Szczeklik W., Sanak M., Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 2004, 114:248-253.
24. Jinnai N., Sakagami T., Sekigawa T., et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 2004, 13:3203-3217.
25. Picado C., Fernandez-Morata J.C., Juan M., et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999, 160:291-296.
26. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994, 46:205-229.
27. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
28. Kim S.H., Kim Y.K., Park H.W., et al. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 2007, 17:295-304.
29. Park B.L., Park S.M., Park J.S., et al. Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep 2010, 43:445-449.
30. Needleman P., Turk J., Jakschik B.A., et al. Arachidonic acid metabolism. Annu Rev Biochem 1986, 55:69-102.
31. Oh S.H., Kim Y.H., Park S.M., et al. Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 2011, 12:351-363.
32. Kim S.H., Choi J.H., Park H.S., et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005, 35:585-590.
33. Kohyama K., Hashimoto M., Abe S., et al. Thromboxane A2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease. Mol Med Report 2012, 5:477-482.
34. Kowalski M.L., Ptasinska A., Jedrzejczak M., et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 2005, 60:1139-1145.
35. Song Y.S., Yang E.M., Kim S.H., et al. Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol 2012, 159:157-161.
36. McMahon B., Godson C. Lipoxins: endogenous regulators of inflammation. Am J Physiol Renal Physiol 2004, 286:F189-F201.
37. Kim H.J., Cho S.H., Park J.S., et al. Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and Aspirin exacerbated respiratory diseases. J Hum Genet 2012, 57:247-253.
38. Feltenmark S., Gautam N., Brunnstrom A., et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci U S A 2008, 105:680-685.
39. Mastalerz L., Setkowicz M., Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep 2005, 5:277-283.
40. Mastalerz L., Setkowicz M., Sanak M., et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004, 113:771-775.
41. Mastalerz L., Setkowicz M., Sanak M., et al. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br J Dermatol 2006, 154:256-260.
42. Kim S.H., Yang E.M., Park H.J., et al. Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity. J Clin Immunol 2007, 27:613-619.
43. Higashi N., Taniguchi M., Mita H., et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004, 113:277-283.
44. Antczak A., Montuschi P., Kharitonov S., et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002, 166:301-306.
45. Szczeklik A., Sladek K., Dworski R., et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608-1614.
46. Fischer A.R., Rosenberg M.A., Lilly C.M., et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994, 94:1046-1056.
47. Sousa A., Pfister R., Christie P.E., et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997, 52:940-945.
48. Varga E.M., Jacobson M.R., Masuyama K., et al. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999, 14:610-615.
49. Nasser S.M., Pfister R., Christie P.E., et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996, 153:90-96.
50. Palikhe N.S., Kim S.H., Cho B.Y., et al. IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma. Allergy Asthma Immunol Res 2010, 2:134-140.
51. Kim S.H., Yang E.M., Lee H.N., et al. Association of the CCR3 gene polymorphism with aspirin exacerbated respiratory disease. Respir Med 2010, 104:626-632.
52. Palikhe N.S., Kim S.H., Cho B.Y., et al. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 2010, 65:338-346.
53. Kim B.S., Park S.M., Uhm T.G., et al. Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 2010, 20:748-758.
54. Bae J.S., Kim S.H., Ye Y.M., et al. Significant association of FcεRIα promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007, 119:449-456.
55. Kim S.H., Kang Y.M., Cho B.Y., et al. Histamine N-methyltransferase 939A>G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria. Allergy 2009, 64:213-221.
56. Laidlaw T.M., Kidder M.S., Bhattacharyya N., et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012, 119:3790-3798.
57. Choi S.J., Ye Y.M., Hur G.Y., et al. Neutrophil activation in patients with ASA-induced urticaria. J Clin Immunol 2008, 28:244-249.
58. Kim S.H., Son J.K., Yang E.M., et al. A functional promoter polymorphism of the human IL-18 gene is associated with aspirin-induced urticaria. Br J Dermatol 2011, 165:976-984.
59. Choi J.H., Lee K.W., Oh H.B., et al. HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. J Allergy Clin Immunol 2004, 113:562-564.
60. Park H.S., Kim S.H., Sampson A.P., et al. The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. J Allergy Clin Immunol 2004, 114:688-689.
61. Kim S.H., Choi J.H., Lee K.W., et al. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin Exp Allergy 2005, 35:339-344.
62. Moffatt M.F., Kabesch M., Liang L., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448:470-473.
63. Himes B.E., Hunninghake G.M., Baurley J.W., et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009, 84:581-593.
64. Li X., Howard T.D., Zheng S.L., et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 2010, 125:328-335.e311.
65. Gudbjartsson D.F., Bjornsdottir U.S., Halapi E., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009, 41:342-347.
66. Kim J.H., Park B.L., Cheong H.S., et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS One 2010, 5:e13818.
67. Kim S.H., Ye Y.M., Palikhe N.S., et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010, 10:280-290.
68. Kim J.H., Park B.L., Pasaje C.F., et al. Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline. J Hum Genet 2011, 56:652-659.
69. Babu K.S., Salvi S.S. Aspirin and asthma. Chest 2000, 118:1470-1476.
70. Lee S.H., Rhim T., Choi Y.S., et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006, 173:370-378.
71. Pasaje C.F., Bae J.S., Park B.L., et al. Association analysis of C6 genetic variations and aspirin hypersensitivity in Korean asthmatic patients. Hum Immunol 2011, 72:973-978.
72. Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 1988, 18:15-20.
73. Filipowicz E., Sanak M. Przegl Lek 2003, 60:185-187. [in Polish].
74. Yoshida S., Sakamoto H., Yamawaki Y., et al. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma. J Allergy Clin Immunol 1998, 102:909-914.
75. Palikhe N.S., Kim S.H., Kim J.H., et al. Role of toll-like receptor 3 variants in aspirin-exacerbated respiratory disease. Allergy Asthma Immunol Res 2011, 3:123-127.
76. Polito A.J., Proud D. Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol 1998, 102:714-718.
77. Pasaje C.F., Kim J.H., Park B.L., et al. A possible association of EMID2 polymorphisms with aspirin hypersensitivity in asthma. Immunogenetics 2011, 63:13-21.
78. Fruth K., Goebel G., Koutsimpelas D., et al. Low SPINK5 expression in chronic rhinosinusitis. Laryngoscope 2012, 122:1198-1204.
79. Bush A., Cole P., Hariri M., et al. Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J 1998, 12:982-988.
80. Marszalek J.R., Ruiz-Lozano P., Roberts E., et al. Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci U S A 1999, 96:5043-5048.
81. Corbit K.C., Shyer A.E., Dowdle W.E., et al. Kif3a constrains beta-catenin-dependent Wnt signaling through dual ciliary and non-ciliary mechanisms. Nat Cell Biol 2008, 10:70-76.
82. Kim J.H., Cha J.Y., Cheong H.S., et al. KIF3A, a cilia structural gene on chromosome 5q31, and its polymorphisms show an association with aspirin hypersensitivity in asthma. J Clin Immunol 2011, 31:112-121.
83. Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265:956-959.
84. Perez G.M., Melo M., Keegan A.D., et al. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol 2002, 168:1428-1434.
85. Oh S.H., Park S.M., Park J.S., et al. Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy Asthma Immunol Res 2009, 1:30-35.
86. Pasaje C.F., Kim J.H., Park B.L., et al. Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Ann Hum Genet 2010, 74:326-334.
87. Kim J.Y., Kim J.H., Park T.J., et al. Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study. BMC Pulm Med 2010, 10:34.
88. Lee J.S., Kim J.H., Bae J.S., et al. Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet 2010, 11:138.
89. Benayoun L., Letuve S., Druilhe A., et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001, 164:1487-1494.
90. Xiang Y.Y., Wang S., Liu M., et al. A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat Med 2007, 13:862-867.
91. Wong W.S., Leong K.P. Tyrosine kinase inhibitors: a new approach for asthma. Biochim Biophys Acta 2004, 1697:53-69.
92. Kumano K., Nakao A., Nakajima H., et al. Blockade of JAK2 by tyrphostin AG-490 inhibits antigen-induced eosinophil recruitment into the mouse airways. Biochem Biophys Res Commun 2000, 270:209-214.
93. Kim J.H., Park B.L., Cheong H.S., et al. Variations in the STK10 gene and possible associations with aspirin-intolerant asthma in a Korean population. J Investig Allergol Clin Immunol 2011, 21:378-388.
94. Lee J.S., Kim J.H., Bae J.S., et al. Association analysis of UBE3C polymorphisms in Korean aspirin-intolerant asthmatic patients. Ann Allergy Asthma Immunol 2010, 105:307-312.
95. Pasaje C.F., Kim J.H., Park B.L., et al. UBE3C genetic variations as potent markers of nasal polyps in Korean asthma patients. J Hum Genet 2011, 56:797-800.
96. Kanazawa H., Kurihara N., Hirata K., et al. Angiotensin II stimulates peptide leukotriene production by guinea pig airway via the AT1 receptor pathway. Prostaglandins Leukot Essent Fatty Acids 1995, 52:241-244.
97. Pasaje C.F., Kim J.H., Park B.L., et al. Association of the variants in AGT gene with modified drug response in Korean aspirin-intolerant asthma patients. Pulm Pharmacol Ther 2011, 24:595-601.
98. Erdos E.G. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension 1990, 16:363-370.
99. Bucknall C.E., Neilly J.B., Carter R., et al. Bronchial hyper-reactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br Med J (Clin Res Ed) 1988, 296:86-88.
100. Kim T.H., Chang H.S., Park S.M., et al. Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 2008, 38:1727-1737.
101. Mingatto F.E., Santos A.C., Uyemura S.A., et al. In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch Biochem Biophys 1996, 334:303-308.
102. Kopff A., Kopff M., Kowalczyk E. Pol Arch Med Wewn 2006, 116:832-837. [in Polish].
103. Mann J.S., Holgate S.T., Renwick A.G., et al. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 1986, 61:1667-1676.
104. Peachell P.T., Lichtenstein L.M., Schleimer R.P. Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther 1991, 256:717-726.
105. Forsythe P., Ennis M. Adenosine, mast cells and asthma. Inflamm Res 1999, 48:301-307.
106. Tilley S.L., Wagoner V.A., Salvatore C.A., et al. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 2000, 105:361-367.
107. Kim S.H., Nam E.J., Kim Y.K., et al. Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in aspirin-induced urticaria. Br J Dermatol 2010, 163:977-985.
108. Palikhe N.S., Kim S.H., Nam Y.H., et al. Polymorphisms of aspirin-metabolizing enzymes CYP2C9, NAT2 and UGT1A6 in aspirin-intolerant urticaria. Allergy Asthma Immunol Res 2011, 3:273-276.
109. Kim J.M., Park B.L., Park S.M., et al. Association analysis of N-acetyl transferase-2 polymorphisms with aspirin intolerance among asthmatics. Pharmacogenomics 2010, 11:951-958.
110. Kohyama K., Abe S., Kodaira K., et al. Polymorphisms of the CYP2C19 gene in Japanese patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2011, 128:1117-1120.
111. Orning L. Omega-oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of omega-hydroxy and omega-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4. Eur J Biochem 1987, 170:77-85.
112. Sala A., Voelkel N., Maclouf J., et al. Leukotriene E4 elimination and metabolism in normal human subjects. J Biol Chem 1990, 265:21771-21778.
113. Kim S.H., Yang E.M., Lee H.N., et al. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy 2009, 64:1221-1225.
114. Kim S.H., Jeong H.H., Cho B.Y., et al. Association of four-locus gene interaction with aspirin-intolerant asthma in Korean asthmatics. J Clin Immunol 2008, 28:336-342.
115. Cheong H.S., Park S.M., Kim M.O., et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011, 66:637-644.